FOXP2 expressed in multiple adult tissues (23, 24) and might act as either a tumor-suppressor or a tumor-stimulator depending on the type of cancers studied (25), presenting a challenge for targeting FOXP2 as a universal target in cancer therapy. This evidence concerns the gene FOXP2 and neoplasm.